Stockreport

Levi & Korsinsky, LLP: CEO and CFO Named as Control Person Defendants in Inovio Pharmaceuticals Securities Action

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Two senior executives of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) are named as individual defendants in a securities cla [Read more]